10 completed, 4 unknown, 2 not yet recruiting, 1 recruiting. 6 Phase 1, 5 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Unknown 2 |
| Not applicable | 5 | Completed 5 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Postprandial Period: new trials by email Literature Review of Postprandial Period trials Research Report on Postprandial Period
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Hypothalamic Microglial Response as a Function of a Meal's Lipid Content in Humans. A Single-center Prospective Cohort Study in Healthy Male Subjects Blood sample, Brain MRI without contrast, performed on an empty stomach and after a meal, Questionnaires - Pathophysiology | Recruiting | Centre Hospitalier Universitaire Dijon | 20 | 2026-09-05 | 2026-09-29 | |
| Study of XNW5004 Tablets in Advanced Prostate Cancer XNW5004 1200 mg BID in Combination with Abiraterone plus Prednisone, XNW5004 1200 mg BID in Combination with Docetaxel plus Prednisone, XNW5004 800 mg or 1200 mg (1:1 randomization), PO, BID; Abiraterone 1000 mg PO, taken on an empty stomach at least 1 hour before and at least 2 hours after a meal, QD; plus Prednisone 5 mg PO BID - Advanced Prostate Cancer | Phase 2 | Not yet recruiting | Evopoint Biosciences Inc. | 242 | 2026-07-13 | 2026-07-28 |
| PPI Refractory - GERD Mechanisms in Systemic Sclerosis educational healthcare intervention, Objective assessment of GI motility, Evaluation of GERD severity - Systemic Sclerosis (SSc), GERD (Gastroesophageal Reflux Disease) | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 147 | 2025-07-01 | 2025-06-15 | |
| Intestinal Perfusion After Feeding in Preterm and Term Infants Evaluation of intestinal perfusion with color Doppler abdominal ultrasound before and after feeding. - Premature, Necrotizing Enterocolitis | Unknown | The Hospital for Sick Children | 20 | 2024-04-02 | 2024-03-20 | |
| Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg 4-MUST, 2 tablets, fasted, 4-MUST, 2 tablets, after meals - Cholecystitis | Phase 1 | Unknown | Valenta Pharm JSC | 24 | 2024-03-19 | 2024-04-02 |
| Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure? exogenous ketone salt supplement, exogenous carbohydrate supplement - Heart Failure | Not applicable | Completed | Université de Sherbrooke | 20 | 2022-12-16 | 2026-01-07 |
| the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome Fasting blood sugar, 2 hours postprandial, HBA1C ,Ultrasound and Doppler study - Gestational Diabetes, Pre-Gestational Diabetes | Unknown | Cairo University | 140 | 2022-06-15 | 2022-08-23 | |
| Heart and Kidney Ketones Metabolism Fasting with exogenous ketone salt supplement, Post-Prandial with exogenous ketone salt supplement - Healthy | Not applicable | Completed | Université de Sherbrooke | 10 | 2020-10-15 | 2023-07-19 |
| The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males Postabsorptive, Postprandial, Immobilisation - Healthy | Not applicable | Completed | University of Exeter | 24 | 2019-04-15 | 2023-03-22 |
| Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets Iloperidone 1 MG, Placebo, fasting - Bioequivalence | Phase 1 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 36 | 2017-11-17 | 2018-02-05 |
| Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation zolpidem hemitartarate tablet 3.5 mg (fasting + post-prandial), zolpidem hemitartarate tablet 3.5 mg (post-prandial + fasting) - Healthy | Phase 1 | Completed | Biolab Sanus Farmaceutica | 28 | 2017-07-05 | 2018-06-11 |
| Single Dose Study of ALZ-801 Prototype Tablets ALZ-801 170 mg Fasting, ALZ-801 205 mg Fasting, ALZ-801 205 mg After Food - Alzheimer Disease | Phase 1 | Completed | Alzheon Inc. | 12 | 2015-09-16 | 2020-10-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791 KQ-791, KQ-791 (after meal), Placebo - Healthy Volunteers, Insulin Resistance | Phase 1 | Completed | Kaneq Bioscience Limited | 19 | 2015-02-01 | 2019-11-26 |
| Maximizing the Anti-inflammatory Effects of Strawberry Bioavailability Before meal, With Meal, After meal - Overweight, Healthy | Not applicable | Completed | Clinical Nutrition Research Center, Illinois Institute of Technology | 22 | 2013-07-01 | 2021-07-27 |
| Acute Effects of Postabsorptive and Postprandial Physical Activity postprandial and postabsorptive physical activity on treadmill - Hyperglycemia, Inflammation | Not applicable | Completed | Inland Norway University of Applied Sciences | 12 | 2013-01-01 | 2015-09-18 |
| A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation pantoprazole, Pradaxa (dabigatran etexilate), Pradaxa, within 30 minutes after a meal - Atrial Fibrillation | Phase 4 | Completed | Boehringer Ingelheim | 1067 | 2011-12-01 | 2015-10-05 |
| Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009) 10 mg MK-0941 DFC (fasted), 10 mg MK-0941 OCT (after meal), 10 mg MK-0941 OCT (before meal) - Type 2 Diabetes Mellitus | Phase 1 | Completed | Merck Sharp & Dohme LLC | 18 | 2007-11-01 | 2015-03-23 |
Alzheimer Disease (1) · Atrial Fibrillation (1) · Cholecystitis (1) · Diabetes Mellitus, Type 2 (1) · Diabetes, Gestational (1) · Enterocolitis, Necrotizing (1) · Fetal Macrosomia (1) · Gastroesophageal Reflux (1) · Heart Failure (1) · Hyperglycemia (1) · Inflammation (1) · Insulin Resistance (1) · Ketosis (1) · Overweight (1) · Premature Birth (1)
Université de Sherbrooke (2) · Alzheon Inc. (1) · Biolab Sanus Farmaceutica (1) · Boehringer Ingelheim (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Cairo University (1) · Centre Hospitalier Universitaire Dijon (1) · Clinical Nutrition Research Center, Illinois Institute of Technology (1) · Evopoint Biosciences Inc. (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Inland Norway University of Applied Sciences (1) · Kaneq Bioscience Limited (1) · Merck Sharp & Dohme LLC (1) · The Hospital for Sick Children (1) · University of Exeter (1)
Canada (4) · China (2) · United States (2) · Brazil (1) · Egypt (1) · France (1) · Russia (1) · United Kingdom (1)
Ann Church, PhD (1) · Britt Burton-Freeman, Ph.D (1) · Hany Saad, MD (1) · Marlou Dirks, PhD (1)